期刊文献+

抗纤灵冲剂对5/6肾切除大鼠尿微量蛋白干预作用 被引量:2

Effect of Kangxianling Medicinal Granules on Urine Small Protein in Rats with 5/6 Nephrectomy
下载PDF
导出
摘要 目的:探讨5/6肾切除大鼠尿微量蛋白的改变以及抗纤灵冲剂干预作用。方法:将40只SD大鼠中30只行5/6肾切除,造模成功后分为正常组、模型组、抗纤灵组、氯沙坦组。药物干预12周后分批处死,留取血液及24小时尿液,检测肾功能(尿素氮、肌酐)以及尿转铁蛋白(TRF)、α1微球蛋白(α1-MG)、β2微球蛋白(β2-MG)、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)以及24小时尿蛋白定量。结果:抗纤灵组及氯沙坦组较模型组肌酐、尿素氮有所下降,降低α1-MG、β2-MG、NAG、TRF。结论:抗纤灵冲剂可明显改善5/6肾切除大鼠的肾功能,在降低尿微量蛋白方面与氯沙坦等效,可能是抗纤灵冲剂通过改善肾小球通透性,加强肾小管的重吸收来降低各种蛋白尿。 Objective:To study change of urine small protein in rats with 5/6 nephrectomy and effect of Kangxianling medicinal granules on it.Methods:SD rats(n=40)were experienced 5/6 nephrectomy,and then randomized into four groups,one with Kangxianling medicinal granules(n=10),one with Cozaar(n=10),one without medicine(n=10),one without 5/6 nephrectomy and medicine(n=10).12 weeks later,urea nitrogen,creatinine,transferring(TRF),α1 microglobulin(α1-MG),β2 microglobulin(β2-MG),N-acetyl-β-D-glucosaminidase(NAG)and 24h urine protein quantitation were tested.Results:The levels of urea nitrogen and creatinine in blood and the levels of α1-MG,β2-MG,NAG and TRF in urine were decreased in group with Kangxianling medicinal granules and group with Cozaar compared with group with 5/6 nephrectomy without medicine(P0.05).Conclusion:Kangxianling medicinal granules could evidently improve renal function and decrease urine small protein in rats with 5/6 nephrectomy,which may be by improving glomerular permeability and enhancing renal tubule reabsorption.
出处 《辽宁中医药大学学报》 CAS 2012年第9期52-54,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 上海市卫生局科研课题项目(2010220) 上海市高校博士学科点专项科研基金资助项目(20093107110006) 上海市教委高校创新团队科研课题项目(201106)
关键词 5/6肾切除模型 尿微量蛋白 肾功能 抗纤灵冲剂 5/6 nephrectomy model urine small protein renal function Kangxianling medicinal granules
  • 相关文献

参考文献9

二级参考文献53

  • 1吴升华,许福熙.内皮素与肾脏疾病[J].国外医学(泌尿系统分册),1994,14(6):250-253. 被引量:9
  • 2袁伟杰,吴灏.脂质肾毒性在肾脏疾病发生发展中的作用[J].继续医学教育,2006,20(5):32-35. 被引量:6
  • 3[3]Jafar TH,Stark Pc,SchmidCH.Proteinuria as emodifiable risk factor for the progression of non-diabetic renal diseases[J].Kidney Int,2001,60:1131-1140.
  • 4[4]Eknoyan C,Levey AS,Levin NW.National epidemic of chronic kidney disease:what we know and what we can do[J].Postgrad Med,2001:110(3):23-29.
  • 5Akcetin Z,Pregla R,Busch A,et al.Lipid peroxidation and the expressional regulation of the heat-shock response during ischemia-reperfusion of rat kidney.Urol Int,2000,65(1):32-36.
  • 6Khwaja A, El Kossi M, Floege J, et al. The management of CKD : A look into the future. Kidney Int, 2007,72:1316 -1323.
  • 7Tuttle KR, Bakris GL, Toto RD, et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care, 2005, 28:2686 - 2690.
  • 8Chatziantoniou C, Dussaule JC. ls kidney injury a reversible process? Curr Opin Nephrol Hypertens, 2005,17:76 - $1.
  • 9Li J, Campanale NV, Liang RJ, et al. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. Am J Pathol, 2006,169:1527 - 1540.
  • 10Bao L, Wang Y, Chang A, et al. Unrestricted c3 activation occurs in crry-deficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol, 2007,18:811 - 822.

共引文献337

同被引文献48

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部